[60], performed ELISA assays on homogenized tumour extracts from breast cancer patients to quantify cytosolic tumour tPA levels and noted that in only the subgroup of patients with lymph node‐negative disease, tPA was associated with better overall survival; no correlations were found in other patient subgroups. The gene discussed is PLAT; the disease is breast cancer.